TREMELIMUMAB-ACTL: 39 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
39
Total FAERS Reports
13 (33.3%)
Deaths Reported
10
Hospitalizations
39
As Primary/Secondary Suspect
3
Life-Threatening
1
Disabilities
Prescription
Status
FDA Application: 761270 ·
First Report: 20221119 · Latest Report: 20230627
What Are the Most Common TREMELIMUMAB-ACTL Side Effects?
#1 Most Reported
Death
5 reports (12.8%)
#2 Most Reported
Colitis
5 reports (12.8%)
#3 Most Reported
Pancytopenia
3 reports (7.7%)
All TREMELIMUMAB-ACTL Side Effects by Frequency
Who Reports TREMELIMUMAB-ACTL Side Effects? Age & Gender Data
Gender: 33.3% female, 66.7% male. Average age: 67.3 years. Most reports from: US. View detailed demographics →
Is TREMELIMUMAB-ACTL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 1 | 1 | 0 |
| 2023 | 18 | 8 | 5 |
What Is TREMELIMUMAB-ACTL Used For?
| Indication | Reports |
|---|---|
| Hepatocellular carcinoma | 25 |
Official FDA Label for TREMELIMUMAB-ACTL
Official prescribing information from the FDA-approved drug label.